导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 17.68% | 1213/2253 |
| 近一周 | -3.49% | 2247/2316 |
| 近一月 | -4.07% | 2076/2312 |
| 近一季 | -13.15% | 2243/2309 |
| 近半年 | -1.58% | 2238/2289 |
| 近一年 | 13.99% | 1370/2247 |
| 近两年 | 1.93% | 1975/2170 |
| 近三年 | -7.38% | 1730/2048 |
| 成立以来 | 73.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
8.91% 240/2331 |
9.67% 189/2353 |
12.49% 1483/2347 |
- - |
| 2024 | -12.77% 2117/2336 |
-6.65% 1811/2322 |
-6.68% 1927/2326 |
10.07% 859/2322 |
-9.02% 2184/2336 |
| 2023 | -11.83% 1325/2330 |
-0.10% 1769/2290 |
-6.13% 1789/2303 |
-6.36% 1295/2318 |
0.41% 276/2330 |
| 2022 | -21.98% 1481/2299 |
-15.43% 1285/2227 |
3.83% 1224/2269 |
-16.78% 2060/2294 |
6.76% 162/2300 |
| 2021 | -6.19% 1836/2205 |
-2.20% 645/1745 |
26.10% 151/2232 |
-12.97% 1961/2560 |
-12.60% 2148/2208 |
| 2020 | 59.19% 522/2086 |
14.33% 23/1036 |
27.02% 395/1256 |
0.75% 1154/1472 |
8.80% 1176/1690 |
| 2019 | 43.45% 515/1974 |
24.20% 1021/3054 |
-1.89% 1963/3201 |
7.83% 336/939 |
9.17% 434/1014 |
| 2018 | -20.86% 1114/1913 |
- - |
- - |
- - |
-19.37% 2857/2977 |
| 2017 | 7.29% 800/1885 |
- - |
- - |
- - |
- - |
| 2016 | -5.63% 534/1510 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 华夏医疗健康混合A VS. () |